SHANGHAI - China's latest antitrust probes, which have hit firms such as Microsoft and Volkswagen AG , are not protectionist tools that favor domestic firms, an official of the country's price regulator told the official China Daily.
BRUSSELS - EU antitrust regulators are asking Facebook's rivals and telecoms operators whether the world No. 1 online social network's proposed $19 billion bid for mobile messaging startup WhatsApp will lead to price hikes and curb innovation.
BEIJING - A Chinese anti-trust regulator said on Monday it has given Microsoft Corp 20 days to reply to queries on the compatibility of its Windows operating system and Office software suite amid a probe into the world's largest software company.
NEW YORK - A year after Goldman Sachs bungled a software upgrade and lost tens of millions of dollars from unintended trades, the 12 U.S. stock options exchanges have crafted new rules for dealing with erroneous transactions, according to draft documents seen by Reuters.
ZURICH - At least 10 Swiss banks have withdrawn from a U.S. program aimed at settling a tax dispute between them and the United States, Swiss newspaper NZZ am Sonntag said on Sunday, quoting unnamed sources.
- Carlyle Group LP has agreed to pay $115 million to settle a lawsuit accusing it of conspiring with other buyout firms not to outbid each other on some takeovers that occurred prior to the financial crisis, a person familiar with the matter said on Friday.
LONDON - Members of the Co-operative Group on Saturday overwhelmingly endorsed a radical shake-up of its board structure, designed to avoid a repeat of the mistakes that brought Britain's biggest mutual to its knees.
NEW YORK - A U.S. judge on Friday dismissed antitrust litigation accusing Wall Street banks and commodity merchants including Goldman Sachs Group Inc and Glencore Plc of conspiring to drive up aluminum prices by reducing supply.
- Takeda Pharmaceutical Co Ltd and Eli Lilly & Co lost a bid to overturn a combined $9 billion punitive damage award by a U.S. jury for hiding cancer risks associated with their Actos diabetes drug, according to a court ruling.
CHICAGO - Henry Jarecki, one of the world's most prominent gold bugs, is a celebrated advocate of free markets with a legendary record in precious metals trading. But this week he became a target of a lawsuit by a young trader who alleges that Jarecki owes him at least $1 million as a share of profits from a new gold trading strategy he has developed.
- Financial: U.S. case dismissal won't dim regulatory glare for base metals sector
- Technology: UPDATE 1-EU seeks rivals' feedback on Facebook, WhatsApp deal
- Healthcare: EU decision on Zimmer's $13.4 bln Biomet deal expected by Oct. 3
- Consumer: INDIA PRESS-Mahindra and Mahindra gears up to drive SUVs, pick-ups into US - Economic Times
- Energy: Texas lawmaker Barton backs lifting oil export ban despite peers' misgivings
- Industrials: Disputed Kurdish oil tanker reappears off Texas coast, still full
- M&A: MOVES-State Street names Keogh head of alternative investment solutions in Asia
- Bankruptcy: KPMG refuses to approve BES accounts, warns of further loss
- IPOs: RLPC-Imperial Tobacco closes $13 bln of loans
- Private Capital: Akzo Nobel CEO solicited for Axalta bid worth more than $7 bln -Bloomberg
- Hedge Funds: Risk-averse UK investors slash equity holdings in August